GlassScriptPhysician profile
Jose Alejandro Fernandez
NPI 1679077499
$2,381.80
in general payments reported to CMS, 2019-2025
16 companies · $724 in 2025
The $724 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,115 · 2024: $543 · 2025: $724.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,344 · Travel and Lodging: $37.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,344.27 |
| Travel and Lodging | $37.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $687.98 | 2023-2025 | Evoke, Evoke Scs |
| Spr Therapeutics, INC | $340.11 | 2023-2025 | Sprint Pns System |
| Abbott Laboratories | $208.53 | 2025 | Eterna |
| Foundation Fusion Solutions, LLC | $181.64 | 2023 | |
| Medtronic, INC. | $168.28 | 2023 | Intellis Adaptivestim |
| Abbvie INC. | $125.00 | 2023 | |
| Gilead Sciences, INC. | $120.97 | 2023 | |
| Celgene Corporation | $115.51 | 2023 | Reblozyl |
| Curonix LLC | $108.84 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Scilex Pharmaceuticals INC. | $94.07 | 2023-2024 | Ztlido |
| Nevro Corp. | $81.45 | 2023 | Senza |
| Glaxosmithkline, LLC. | $46.53 | 2025 | Zejula, Jemperli |
| Pfizer INC. | $39.75 | 2023 | |
| Seagen INC. | $38.70 | 2023 | Tukysa |
| Astrazeneca Pharmaceuticals LP | $24.44 | 2023 | Lynparza |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Fernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.